1012633

Salbutamol hemisulfate salt

United States Pharmacopeia (USP) Reference Standard

• Synonyme(s) : Salbutamol hemisulfate salt, α₁-[(tert-Butylamino)methyl]-4-hydroxy-1,3-benzenedimethanol hemisulfate salt, Albuterol sulfate
• Formule empirique (notation de Hill): C₁₃H₂₁NO₃ · 0.5H₂SO₄
• Numéro CAS: 51022-70-9
• Poids moléculaire : 288.35
• Numéro MDL: MFCD00055200
• Code UNSPSC : 41116107
• ID de substance PubChem : 329748947
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: pharmaceutical primary standard
• Famille d'API: salbutamol, albuterol
• Fabricant/nom de marque: USP
• Application(s): pharmaceutical (small molecule)
• Format: neat
• Chaîne SMILES: OS(O)(=O)=O.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c2ccc(O)c(CO)c2
• InChI: 1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)
• Clé InChI: BNPSSFBOAGDEEL-UHFFFAOYSA-N
• Informations sur le gène: human ... ADRB2(154)

Description

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

• Albuterol sulfate in pediatric pharmacology: A study evaluated the medication management for children with complex medical conditions using Albuterol sulfate among other medications. This research highlights its critical role in pediatric respiratory therapies, emphasizing its safety and efficacy (Quinn et al., 2024).


• Nebulizer comparison in COPD: Albuterol sulfate′s delivery via different nebulizers was analyzed for effectiveness in treating chronic obstructive pulmonary disease (COPD). The study provides valuable insights into its application in respiratory care, particularly in optimizing delivery methods for enhanced patient outcomes (Feng et al., 2024).


• siRNA delivery in lung therapy: The potential of β(2)-agonists including Albuterol sulfate was explored as adjuvants in siRNA delivery for treating pulmonary diseases. This innovative approach underscores its utility beyond conventional bronchodilation, marking significant advancements in respiratory therapy research (Merckx et al., 2024).

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS07
• Mention d'avertissement: Warning
• Mentions de danger: H317,H351,H361fd
• Conseils de prudence: P202 - P261 - P272 - P280 - P302 + P352 - P308 + P313
• Classification des risques: Carc. 2 - Repr. 2 - Skin Sens. 1
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable